Venture Capital Investors

TL Ventures

TL Ventures is a venture capital investment firm that provides investment funds to select companies.

Venture Investor Overview

Venture Investor
TL Ventures
Status
InActive
Investor Type
Venture Capital
Activity Level
119 transactions
Funds Raised
Unknown
Industry Focus
Internet & IoT

Contact Information

Contact
Robert Keith
Title
Managing Director
Mailing Address
435 Devon Park Dr. Building 700
Wayne, PA 19087
USA
Phone
(610) 971-1515
Website
www.tlventures.com
Email Address
Not Recorded

Background Information

Overview
TL Ventures, established in 1988, has over $1.4 billion under management. Focused on venture investing in category-defining, early-stage companies in software, communications, information infrastructure and business services, the Firm provides portfolio companies with operational, entrepreneurial and financial expertise and a global network of resources and contacts.
Profile
TL Ventures LinkedIn Company Profile
Social Media
TL Ventures Company Twitter Account
Company News
TL Ventures News
Facebook
TL Ventures on Facebook
YouTube
TL Ventures on YouTube
Last Transaction
10/30/2015

Transaction History

Our records indicate that TL Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Tradiv
10/30/2015
$1,000,000
Donuts
3/31/2015
$54,172,000
Salem Education
6/30/2014
$634,000
iSpot.tv
10/8/2013
$5,000,000
Global Education Learning
9/30/2013
$2,700,000
Finite Carbon
6/30/2013
$150,000
Donuts
6/30/2013
$17,391,000
Finite Carbon
12/31/2012
$200,000
Mismi
12/31/2012
$2,434,000
Moonshoot
9/30/2012
$230,000
Global Education Learning
6/30/2012
$8,000,000
Pivotal Systems
6/30/2012
$200,000
Moonshoot
6/30/2012
$160,000
Donuts
6/6/2012
$100,000,000
Moonshoot
3/31/2012
$360,000
AirWalk Communications
3/31/2012
$383,000
Noble Biomaterials
2/10/2012
$8,000,000
Moonshoot
6/30/2011
$1,950,000
Celator Pharmaceuticals
6/30/2011
$5,000,000
Pivotal Systems
6/30/2011
$1,500,000
SkyCross
5/17/2011
$11,000,000
Pivotal Systems
12/31/2010
$1,750,000
AirWalk Communications
12/31/2010
$10,000,000
Maskless Lithography
12/31/2010
$2,522,000
Celator Pharmaceuticals
9/1/2010
$20,000,000
Mismi
3/31/2010
$754,000
Pivotal Systems
3/31/2010
$2,100,000
Moonshoot
2/18/2010
$6,600,000
Sopherion Therapeutics
12/31/2009
$2,600,000
Agile Therapeutics
12/31/2009
$1,005,200
AirWalk Communications
9/30/2009
$5,000,000
Advanced Inquiry Systems
8/18/2009
$11,000,000
Finite Carbon
7/13/2009
$2,000,000
Mismi
6/30/2009
$2,801,000
Optichron
6/30/2009
$616,000
Metallect
6/30/2009
$100,000
Maskless Lithography
1/20/2009
$29,500,000
VeriWave
12/31/2008
$10,005,000
Ciclon Semiconductor Device
12/31/2008
$2,000,000
Advanced Inquiry Systems
12/31/2008
$1,200,000
VeriWave
9/30/2008
$2,474,000
Axioma
9/30/2008
$5,000,000
Celator Pharmaceuticals
7/29/2008
$22,500,000
Spire Company Associates
7/8/2008
$9,000,000
Pivotal Systems
6/30/2008
$1,669,000
Metallect
6/30/2008
$600,000
Correctnet
6/30/2008
$1,250,000
ScaleMP
4/1/2008
$8,000,000
Circadiant Systems
3/31/2008
$300,000
Spire Company Associates
3/31/2008
$1,000,000
Pivotal Systems
3/31/2008
$1,331,000
Kleer
3/24/2008
$7,000,000
StrataLight Communications
12/31/2007
$28,568,000
Agile Therapeutics
12/27/2007
$17,600,000
NorthStar Systems International
11/13/2007
$18,000,000
Optichron
10/22/2007
$12,000,000
Sopherion Therapeutics
9/30/2007
$6,000,000
Ventaira Pharmaceuticals
9/30/2007
$1,942,000
Advanced Inquiry Systems
9/30/2007
$8,000,000
Celator Pharmaceuticals
8/2/2007
$10,000,000
VeriWave
6/30/2007
$4,750,000
Apogee Photonics
6/30/2007
$8,647,000
StrataLight Communications
6/30/2007
$10,000,200
QuatRx Pharmaceuticals
5/22/2007
$44,000,000
NetEffect
5/9/2007
$8,000,000
Apogee Photonics
3/31/2007
$600,000
ScaleMP
3/31/2007
$5,500,000
Ciclon Semiconductor Device
3/5/2007
$12,000,000
Circadiant Systems
12/31/2006
$1,762,000
Atrenta
10/19/2006
$16,000,000
AirWalk Communications
10/16/2006
$15,000,000
Maskless Lithography
9/30/2006
$2,998,000
Axioma
9/30/2006
$2,620,000
Ventaira Pharmaceuticals
9/30/2006
$5,000,000
NetEffect
7/24/2006
$25,000,000
VeriWave
6/30/2006
$8,500,000
BLAZE
6/30/2006
$1,980,000
Apogee Photonics
6/30/2006
$5,000,000
Circadiant Systems
6/30/2006
$2,551,000
Axioma
6/30/2006
$1,000,000
Correctnet
6/28/2006
$5,000,000
Agile Therapeutics
5/25/2006
$12,000,000
Correctnet
3/31/2006
$1,010,000
ClariFI
3/31/2006
$3,500,000
AirWalk Communications
3/31/2006
$700,000
Metallect
3/31/2006
$2,000,100
SkyCross
1/3/2006
$14,000,000
Ciclon Semiconductor Device
10/26/2005
$12,000,000
Axerra Networks
9/19/2005
$16,250,000
Intellon
8/24/2005
$24,500,000
Apogee Photonics
7/26/2005
$9,700,000
Aberdeen Group
6/30/2005
$1,000,000
StarCite
6/30/2005
$3,123,000
VeriWave
6/15/2005
$10,000,000
Optichron
6/6/2005
$17,000,000
Celator Pharmaceuticals
5/3/2005
$40,000,000
Metallect
3/31/2005
$2,200,000
Noble Biomaterials
3/31/2005
$13,000,000
StarCite
3/31/2005
$1,500,000
ScaleMP
3/31/2005
$3,750,000
Circadiant Systems
3/31/2005
$2,000,000
Maskless Lithography
3/31/2005
$7,175,000
Ventaira Pharmaceuticals
3/30/2005
$13,500,000
QuatRx Pharmaceuticals
12/13/2004
$31,000,000
Sopherion Therapeutics
9/6/2004
$47,000,000
Sonics
6/22/2004
$10,000,000
Atrenta
6/8/2004
$11,000,000
NetEffect
5/10/2004
$22,000,000
Intellon
4/5/2004
$23,500,000
Zalicus
3/10/2004
$30,000,000
Netrake
1/19/2004
$20,000,000
StrataLight Communications
12/19/2003
$19,500,000
AirWalk Communications
12/15/2003
$8,000,000
OEwaves
10/20/2003
$6,000,000
Atrenta
8/5/2003
$5,300,000
ImmunGene
7/11/2003
$25,000,000
QuatRx Pharmaceuticals
6/10/2003
$28,000,000
BayPackets
3/10/2003
$21,700,000
BattellePharma
2/19/2003
$22,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Mark DeNino
  Mark DeNino LinkedIn Profile  Mark DeNino Twitter Account  Mark DeNino News  Mark DeNino on Facebook
Managing Director
Robert Keith
  Robert Keith LinkedIn Profile  Robert Keith Twitter Account  Robert Keith News  Robert Keith on Facebook
Partner
Robert McParland
  Robert McParland LinkedIn Profile  Robert McParland Twitter Account  Robert McParland News  Robert McParland on Facebook
Partner
Robert Verratti
  Robert Verratti LinkedIn Profile  Robert Verratti Twitter Account  Robert Verratti News  Robert Verratti on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

TL Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Aberdeen Group
Advanced Inquiry Systems
Agile Therapeutics
AirWalk Communications
Apogee Photonics
Atrenta
Axerra Networks
Axioma
BattellePharma
BayPackets
BLAZE
Celator Pharmaceuticals
Ciclon Semiconductor Device
Circadiant Systems
ClariFI
Correctnet
Donuts
Finite Carbon
Global Education Learning
ImmunGene
Intellon
iSpot.tv
Kleer
Maskless Lithography
Metallect
Mismi
Moonshoot
NetEffect
Netrake
Noble Biomaterials
NorthStar Systems International
OEwaves
Optichron
Pivotal Systems
QuatRx Pharmaceuticals
Salem Education
ScaleMP
SkyCross
Sonics
Sopherion Therapeutics
Spire Company Associates
StarCite
StrataLight Communications
Tradiv
Ventaira Pharmaceuticals
VeriWave
Zalicus

 

 

 

 

Browse more venture capital investors:

TL Capital Group | TLcom Capital

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.